Envoy Medical (COCH) Competitors $1.43 -0.17 (-10.69%) (As of 12:28 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends COCH vs. TLSI, ECOR, TELA, SRTS, LNSR, FONR, GUTS, MGRM, EDAP, and NSPRShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include TriSalus Life Sciences (TLSI), electroCore (ECOR), TELA Bio (TELA), Sensus Healthcare (SRTS), LENSAR (LNSR), FONAR (FONR), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry. Envoy Medical vs. TriSalus Life Sciences electroCore TELA Bio Sensus Healthcare LENSAR FONAR Fractyl Health Monogram Orthopaedics Edap Tms InspireMD Envoy Medical (NASDAQ:COCH) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment. Does the media refer more to COCH or TLSI? In the previous week, TriSalus Life Sciences had 2 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for TriSalus Life Sciences and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.00 beat TriSalus Life Sciences' score of 0.68 indicating that Envoy Medical is being referred to more favorably in the media. Company Overall Sentiment Envoy Medical Positive TriSalus Life Sciences Positive Which has better valuation & earnings, COCH or TLSI? Envoy Medical has higher earnings, but lower revenue than TriSalus Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$278K104.07-$29.91MN/AN/ATriSalus Life Sciences$26.89M5.56-$59.04M-$2.49-1.97 Which has more risk and volatility, COCH or TLSI? Envoy Medical has a beta of 2.23, suggesting that its share price is 123% more volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Is COCH or TLSI more profitable? TriSalus Life Sciences has a net margin of -206.24% compared to Envoy Medical's net margin of -7,607.55%. Company Net Margins Return on Equity Return on Assets Envoy Medical-7,607.55% N/A -262.28% TriSalus Life Sciences -206.24%N/A -236.83% Do analysts rate COCH or TLSI? Envoy Medical presently has a consensus target price of $8.00, suggesting a potential upside of 459.83%. TriSalus Life Sciences has a consensus target price of $11.79, suggesting a potential upside of 140.52%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than TriSalus Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Do insiders & institutionals believe in COCH or TLSI? 8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 60.5% of Envoy Medical shares are held by company insiders. Comparatively, 32.8% of TriSalus Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in COCH or TLSI? TriSalus Life Sciences received 4 more outperform votes than Envoy Medical when rated by MarketBeat users. CompanyUnderperformOutperformEnvoy MedicalOutperform Votes7100.00% Underperform VotesNo VotesTriSalus Life SciencesOutperform Votes11100.00% Underperform VotesNo Votes SummaryTriSalus Life Sciences beats Envoy Medical on 8 of the 15 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.93M$9.52B$5.17B$9.03BDividend YieldN/A1.41%4.96%4.20%P/E RatioN/A19.2787.1417.05Price / Sales104.0733.441,125.75118.75Price / CashN/A22.3043.2737.84Price / Book-15.885.694.824.94Net Income-$29.91M$182.72M$120.07M$225.13M7 Day Performance-10.69%2.65%1.02%3.71%1 Month Performance-37.32%-6.41%16.06%2.47%1 Year Performance-21.08%-12.73%28.43%17.10% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical3.0924 of 5 stars$1.43-10.7%$8.00+459.8%-11.6%$28.93M$278,000.000.0034Short Interest ↓Positive NewsGap DownTLSITriSalus Life Sciences3.8937 of 5 stars$4.07+0.5%$11.79+189.6%-42.7%$124.11M$26.89M-1.63106Short Interest ↑News CoverageECORelectroCore2.6943 of 5 stars$17.50+14.6%$25.00+42.9%+184.3%$114.71M$23.33M-9.5650Short Interest ↑High Trading VolumeTELATELA Bio2.5733 of 5 stars$2.89+1.4%$9.25+220.1%-56.0%$113.83M$68.65M-1.71120Gap UpSRTSSensus Healthcare3.1691 of 5 stars$6.89-3.0%$12.50+81.4%+205.5%$112.92M$41.31M12.0940Short Interest ↑News CoverageGap DownLNSRLENSAR0.6262 of 5 stars$8.69+12.9%$8.00-7.9%+138.7%$100.93M$48.87M-5.95110Gap DownHigh Trading VolumeFONRFONAR1.2104 of 5 stars$14.97-1.1%N/A-23.6%$94.73M$102.01M10.69480Short Interest ↑News CoverageGUTSFractyl Health1.3194 of 5 stars$1.90+5.9%$22.00+1,060.9%N/A$91.15M$97,000.00-0.16102MGRMMonogram Orthopaedics2.4557 of 5 stars$2.55-1.2%$4.00+56.9%-24.1%$87.50M$364,999.00-5.4328Short Interest ↑EDAPEdap Tms2.0279 of 5 stars$2.23+1.8%$19.00+752.0%-58.9%$82.74M$63.41M-3.43307Positive NewsNSPRInspireMD2.3712 of 5 stars$2.93-2.3%$4.75+62.1%-4.3%$76.43M$6.82M-3.9150Analyst Forecast Related Companies and Tools Related Companies TriSalus Life Sciences Competitors electroCore Competitors TELA Bio Competitors Sensus Healthcare Competitors LENSAR Competitors FONAR Competitors Fractyl Health Competitors Monogram Orthopaedics Competitors Edap Tms Competitors InspireMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:COCH) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Elon Spotted at Weird Facility in Memphis? What Elon Musk is planning at a remote facility in Memphis may be his greatest achievement to date. Because...Paradigm Press | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
